Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells

Protein Expression and Purification

Volumn 28, Issue 2, 2003, Pages 252-258

  Galfione, Matthew ^a   Luo, Weiping ^a   Kim, Jeri ^a   Hawke, David ^a   Kobayashi, Ryuji ^a   Clapp, Carmen ^b   Yu Lee, Li Yuan ^c   Lin, Sue Hwa ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI; INSECTA;

EID: 0038057564     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(02)00639-3     Document Type: Article

References (22)

1. N. Ben-Jonathan, J.L. Mershon, D.L. Allen, R.W. Steinmetz, Extrapituitary prolactin: distribution, regulation, function and clinical aspects, Endocr. Rev. 17 (1996) 639-669.
2. C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, P.A. Kelly, Prolactin and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice, Endocr. Rev. 19 (1998) 225-268.
3. Y.N. Sinha, Structural variants of prolactin: occurrence and physiological significance, Endocr. Rev. 16 (1995) 354-369.
4. R.A. Baldocchi, L. Tan, D.S. King, C.S. Nicoll, Mass spectrometric analysis of the fragments produced by cleavage and reduction of rat prolactin: evidence that the cleaving enzyme is cathepsin D, Endocrinology 133 (1993) 935-938.
5. C. Clapp, J.A. Martial, R.C. Guzman, F. Rentier-Delrue, R.I. Weiner, The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis, Endocrinology 133 (1993) 1292-1299.
6. N. Ferrara, C. Clapp, R. Weiner, The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells, Endocrinology 129 (1991) 896-900.
7. I. Struman, F. Bentzien, H. Lee, V. Mainfroid, G. D'Angelo, V. Goffin, R.I. Weiner, J.A. Martial, Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis, Proc. Natl. Acad. Sci. USA 96 (1999) 1246-1251.
8. Z. Duenas, L. Torner, A.M. Corbacho, A. Ochoa, G. Gutierrez-Ospina, F. Lopez-Barrera, F.A. Barrios, P. Berger, G.M. de la Escalera, C. Clapp, Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules, Invest. Ophthalmol. Vis. Sci. 40 (1999) 2498-2505.
9. M.M. Compton, R.J. Witorsch, Proteolytic fragmentation of rat prolactin by the rat ventral prostate gland, Prostate 4 (1983) 231-246.
10. M.M. Compton, R.J. Witorsch, Proteolytic degradation and modification of rat prolactin by subcellular fractions of the rat ventral prostate gland, Endocrinology 115 (1984) 476-484.
11. C. Clapp, Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat. Characterization of the cleaved and 16k forms, Endocrinology 121 (1987) 2055-2064.
12. C. Clapp, L. Torner, G. Gutierrez-Ospina, E. Icantara, F.J. Lopez-Gomez, M. Nagano, P.A. Kelly, S. Mejia, M.A. Morales, G.M. De La Esclera, The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin, Proc. Natl. Acad. Sci. USA 91 (1994) 10384-10388.
13. V.L. Wong, M.M. Compton, R.J. Witorsch, Proteolytic modification of rat prolactin by subcellular fractions of the lactating rat mammary gland, Biochim. Biophys. Acta 881 (1986) 167-174.
14. R.S. Vick, V.L. Wong, R.J. Witorsch, Biological, immunological and biochemical characterization of cleaved prolactin generated by lactating mammary gland, Biochim. Biophys. Acta 931 (1987) 196-204.
15. C. Clapp, R.I. Weiner, A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells, Endocrinology 130 (1992) 1380-1386.
16. G.D. D'Angelo, I. Struman, J. Martial, R.I. Weiner, Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin, Proc. Natl. Acad. Sci. USA 92 (1995) 6374-6378.
17. H. Lee, I. Struman, C. Clapp, J. Martial, R.I. Weiner, Inhibition of urokinase activity by the antiangiogenic factor 16k prolactin: activation of plasminogen activator inhibitor I expression, Endocrinology 139 (1998) 3696-3703.
18. J.-F. Martini, C. Piot, L.M. Humeau, I. Struman, J.A. Martial, R.I. Weiner, The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation, Mol. Endocrinol. 14 (2000) 1536-1549.
19. Y.N. Sinha, Structural variants of prolactin: occurrence and physiological significance, Endocr. Rev. 16 (1995) 354-369.
20. K.D. O'Neal, D.W. Montgomery, T.M. Truong, L.-y. Yu-Lee, Prolactin gene expression in human thymocytes, Mol. Cell. Endocrinol. 87 (1992) R19-R23.
21. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
22. D.D. Bannerman, R.D. Erwert, R.K. Winn, J.M. Harlan, TIRAP mediates endotoxin-induced NF-kappaB activation and apoptosis in endothelial cells, Biochem. Biophys. Res. Commun. 295 (2002) 157-162.